No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Remains a Hold on Adicet Bio (ACET)
Adicet Bio Advances With Phase 1 Trial of ADI-270
HC Wainwright & Co. Reiterates Neutral on Adicet Bioto Neutral
Express News | Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of Adi-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Express News | Adicet Bio Appoints Julie Maltzman, M.d. as Chief Medical Officer